title: Studies on nitric oxide free radicals generated from polymorphonuclear leukocytes (PMN) stimulated by phorbol myristate acetate (PMA).
abstract: The interaction of NO and O2- free radicals generated from PMA (phorbol myristate acetate)-stimulated PMN (polymorphonuclear leukocytes) was studied by a nitroxide spin trap, DMPO (5,5-dimethyl-1-pyrroline-1-oxide). It was found that addition of L-arginine to the system would significantly decrease the trapped O2- by DMPO and addition of NG-monomethyl-arginine (NGMA) would significantly increase the trapped O2- by DMPO. It was proved that the formation of ONOO- by the reaction of NO and O2- was the main reason for the decrease of trapped O2- in the experiment with xanthine/xanthine oxidase and irradiation of riboflavin systems. The yield of NO during this process was calculated. The generation dynamic of NO was studied by a luminol-dependent chemiluminescence technique and it was found that after stimulation of PMN by PMA, there would be an immediate, significant chemiluminescence, which came mainly from the active oxygen free radicals generated by PMN. If L-arginine was added to this system, the chemiluminescence would increase about 100-fold, but NGMA inhibited the increase of the chemiluminescence. Ten minutes after addition of L-arginine, this increase did not change, the chemiluminescence peak decreased gradually, but the half life increased. The ESR and chemiluminescence properties of NO and ONOO- synthesized were also studied in model systems.
authors.affiliation: Institute of Biophysics, Academia Sinica, Beijing, China.
authors.forename: B L
authors.initials: BL
authors.lastname: Zhao
authors.forename: J C
authors.initials: JC
authors.lastname: Wang
authors.forename: J W
authors.initials: JW
authors.lastname: Hou
authors.forename: W J
authors.initials: WJ
authors.lastname: Xin
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D003497:Cyclic N-Oxides; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D008163:Luminescent Measurements; D008165:Luminol; D009504:Neutrophils / Q000187:drug effects / Q000201:enzymology*; D009569:Nitric Oxide / Q000096:biosynthesis*; D013113:Spin Labels; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D019820:Xanthine; D014969:Xanthine Oxidase / Q000378:metabolism; D014970:Xanthines / Q000378:metabolism; D019323:omega-N-Methylarginine
chemical_list: D003497:Cyclic N-Oxides; D004791:Enzyme Inhibitors; D005609:Free Radicals; D013113:Spin Labels; D014970:Xanthines; D019820:Xanthine; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D008165:Luminol; C017245:5,5-dimethyl-1-pyrroline-1-oxide; D001120:Arginine; D014969:Xanthine Oxidase; D013755:Tetradecanoylphorbol Acetate